- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, July 30, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by BenefitsPRO referenced a study published in the July 2021 issue of The American Journal of Managed Care® (AJMC®), titled “Reduced Medical Spending Associated With Integrated Pharmacy Benefits.” In the study, authors found that Blue Cross and Blue Shield of Louisiana members covered by an integrated pharmacy benefit, as opposed to a pharmacy carve-out, experienced slower growth in medical spending.
A piece by Fierce Pharma cited an article by AJMC®’s sister site The Center for Biosimilars®, titled “FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar.” The article covered the FDA’s approval of Biocon Biologics’ Semglee insulin glargine as an interchangeable biosimilar, referencing Lantus.
An article by the Center for American Progress referenced a June 2019 contributor post published on AJMC.com, the website of AJMC®. The contributor article, titled “The Deadly Costs of Insulin,” details the significant price increases of insulin treatment, from $14 for 1 vial in 2001 to $275 in 2019.
Another piece by Fierce Pharma included an article from The Center for Biosimilars®. The article, “Pfizer Resolves Antitrust Lawsuit With J&J Over Remicade,” covered a Pfizer settlement with Johnson & Johnson (J&J) over a long-running dispute in which J&J was alleged to have blocked payers from covering Inflectra.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Demographic Disparities in Video Visit Telemetry: Understanding Telemedicine Utilization
March 7th 2025A stratified demographics analysis of video visit telemetry data reveals that age older than 65 years and African American/Black race are associated with higher video visit failure rates, whereas language, sex, and ethnicity are not.
Read More
